AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 257: E139-E144, 1989;
0193-1849/89 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tokuyama, K.
Right arrow Articles by Himms-Hagen, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tokuyama, K.
Right arrow Articles by Himms-Hagen, J.

AJP - Endocrinology and Metabolism, Vol 257, Issue 2 E139-E144, Copyright © 1989 by American Physiological Society


ARTICLES

Adrenalectomy prevents obesity in glutamate-treated mice

K. Tokuyama and J. Himms-Hagen
Department of Biochemistry, University of Ottawa, Ontario, Canada.

Mice treated with monosodium glutamate (MSG) in the neonatal period grow into obese, stunted adults without overeating. We have previously demonstrated normal control of brown adipose tissue (BAT) thermogenic function in the MSG-treated mouse and have concluded that thermoregulation at a lower than normal body temperature for most of the time is a major cause of its obesity. The objective of the present experiments was to find out whether adrenalectomy would prevent obesity in the MSG-treated mouse, as it does in hyperphagic obese rodents, and whether the thermoregulatory anomaly would be prevented by this procedure. MSG-treated mice that were adrenalectomized at 5 wk of age and studied at 10 wk of age did not become obese. Adrenalectomy increased body temperature of MSG-treated mice to normal (male mice) or almost normal (female mice). Adrenalectomy increased BAT mitochondrial guanosine 5'-diphosphate binding in MSG-treated mice, indicative of an increased thermogenic state, but had the same effect in control mice. We conclude that obesity in the MSG-treated mouse is secondary to the high level of corticosterone in its blood, which raises its metabolic efficiency, an effect of corticosterone also seen in normal lean mice, and causes it to thermoregulate at a low energy-conserving level. This latter effect is peculiar to the MSG-treated mouse and is not seen in corticosterone-treated normal mice.


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. W. Haller, L. E. Wittmers Jr., I. V. Haller, and R. R. Regal
The obese gene is expressed in lean littermates of the genetically obese mouse (C57BL/6J ob/ob)
Am J Physiol Endocrinol Metab, April 1, 1999; 276(4): E762 - E765.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. Arvaniti, Y. Deshaies, and D. Richard
Effect of leptin on energy balance does not require the presence of intact adrenals
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 1998; 275(1): R105 - R111.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online